Taking vacations could prolong life. That's the finding of a 40-year study presented today at ESC Congress and accepted for publication in The Journal of Nutrition, Health & Aging.
Aug 28, 2018
0
16
(HealthDay)—Treating mice fed a high-fat diet with telmisartan reverses insulin resistance and glucose intolerance, but only when the peroxisome proliferator-activated receptor-δ (PPAR-δ) gene is present, according to ...
Jan 3, 2013
0
0
With much of the nation facing a heat advisory this weekend, the American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, is urging people to take precautions to protect ...
Jul 19, 2019
0
2
Record high temperatures are bringing summer heat early this year around much of the U.S., and the American Heart Association, a global force for longer, healthier lives for all, is urging people to take extra steps to protect ...
Jun 15, 2022
0
7
Combination treatments with two or more blood pressure drugs can significantly reduce blood pressure in patients taking ibrutinib, according to a new study published in Blood Advances.
Feb 5, 2024
0
0
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
Sep 19, 2019
0
5
When COVID-19 was first seen in the United States, now more than a year ago, doctors considered it a respiratory ailment. But that didn't last long.
Feb 11, 2021
0
5
A multifaceted intervention to improve prescribing practices increased the likelihood that patients with type 2 diabetes and heart disease would be prescribed three classes of guideline-recommended medications by more than ...
Mar 7, 2023
0
24
(HealthDay)—A potential COVID-19 survival benefit is suggested in association with initiation or continuation of an angiotensin-converting enzyme inhibitor (ACE-I), an angiotensin receptor blocker (ARB), or metformin for ...
Jan 10, 2022
0
13
(HealthDay)—For patients with hypertension hospitalized with COVID-19 infections, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) are not associated with the severity or mortality of ...
Apr 23, 2020
0
1
